At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 600 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 2
- ✓Malignant and intermediate and selected benign bone or soft tissue tumors per WHO coding list of the SSN
- ✓Female and male subjects of all ages
Key exclusion· 1
- ✕Documented objection to subsequent use of personal health data
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
In Brief
An observational study for Sarcoma. Currently recruiting, targeting 600 participants across 8 sites.
Signals
Enrolling ahead of pace
Detailed Summary
The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoma
CountriesSwitzerland
CollaboratorsSwiss Sarcoma Network
Timeline
N/ARecruiting
20202021202220232024202520262027202820292030
Enrollment StartOct 2019
First PostedMar 2020
TodayJul 2026
Primary CompletionDec 2029
First PostedMar 9, 2020
Enrollment StartOct 19, 2019
Primary CompletionDec 31, 2029
TodayJul 2, 2026
Enrollment to primary: 10.2 yearsPosted 6.3 years agoPrimary completion in 3.5 years